Tabac et cannabis en psychiatrie : impacts et enjeux cliniques
Soins Psychiatrie · 2026
DOI: 10.1016/j.spsy.2025.11.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Soins Psychiatrie, 2026. Verfasst von Safia Zah. Beteiligte Einrichtung: Service Addictions, Pôle clinique transversal, Groupe hospitalier Fondation Vallée-Paul Guiraud, GHT Psy Sud Paris, 54 avenue de la République, BP 20…. Hauptthemen laut MEDLINE: Marijuana Abuse, Mental Disorders, Tobacco Use Disorder. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
In psychiatry, dual pathology is increasingly common and requires an integrated approach. Tobacco use is ubiquitous and cannabis exacerbates all psychopathologies. Neurobiological mechanisms explain why these substances continue to be used. Their management remains insufficiently supervised by healthcare professionals, even though they cause somatic complications that reduce patients' life expectancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service Addictions, Pôle clinique transversal, Groupe hospitalier Fondation Vallée-Paul Guiraud, GHT Psy Sud Paris, 54 avenue de la République, BP 20065, 94806 Villejuif cedex, France. Electronic address: safia.zah@gh-p…
Zitieren
APA
Zah, S. (2026). Tabac et cannabis en psychiatrie : impacts et enjeux cliniques. Soins Psychiatrie. https://doi.org/10.1016/j.spsy.2025.11.010
Vancouver
Zah S. Tabac et cannabis en psychiatrie : impacts et enjeux cliniques. Soins Psychiatrie. 2026. doi:10.1016/j.spsy.2025.11.010
BibTeX
@article{Zah2026,
author = {Zah, Safia},
title = {Tabac et cannabis en psychiatrie : impacts et enjeux cliniques},
journal = {Soins Psychiatrie},
year = {2026},
doi = {10.1016/j.spsy.2025.11.010}
}
EUVIMED